Felton, 26 November
2019 - In Vitro Diagnostics (IVD) Quality Control
Market is anticipated to reach USD 1.13 billion by 2024. The rising
number of certified clinical laboratories requires quality control (QC)
services to maintain their standards, associated with the increasing acceptance
of third party providers of quality control services, to ensure the accurate
and reproducible test results, and better outcomes which is anticipated to
drive the growth.
For the establishment of definite standards of quality, the
internal Quality Control (QC) programs and the external QAS (Quality Assurance
Schemes) is very important to ensure validity and reliability of the test
results obtained by the IVD devices. These programs are essential in confirming
the delivery of patient diagnostic outcomes, which are reliable and without
errors, such as misdiagnosis because of device-related errors, which can impact
the health of the patient.
Request a PDF Sample
@ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market/request-sample
Type Insights
On the type basis, the IVD quality control market is
categorized into quality assurance services quality control (QC), and data
management. The QC schemes are appropriate to plasma-based, whole blood-based
and serum-based products. In 2016, QC market was one of the largest segments
because of the rapidly developing IVD technologies and the existence of
numerous internal QC programs for the different features of the IVD device-based
procedures of testing
Application
Insights
There are numerous applications of the IVDs, which includes
haematology, immunology, coagulation, clinical chemistry, molecular diagnostics
and microbiology. Amongst these all, molecular diagnostics is anticipated to be
the fastest growing market segment with 4.88% CAGR. The frequent usage of the
technologies in the molecular diagnostics, such as gene expression and PCR,
high accuracy and specificity are some of the responsible factors associated
with its high growth.
End-use Insights
The hospitals market segment was valued the largest market
segment of over 46.0% in 2016 owing to the high application of IVD tests in
hospitals and the necessity of obedience with the IVD directives for the
product traceability. The home care market segment is anticipated to observe a
lucrative progression owing to the persistent increase in the usage devices for
point-of-care testing. The rise in adoption of microchip technology which is
used to handle fluids in IVD equipment, as well as the enhanced production
processes and the miniaturization technology are creating efficient
point-of-care devices, which are very less susceptible to errors.
Market Segments
IVD Quality Control
Market Application Outlook, by Revenue (USD Million, 2013 - 2024)
• Clinical
Chemistry
• Immunochemistry
• Hematology
• Others
IVD Quality Control
Market Type Outlook, by Revenue (USD Million), 2013 - 2024
• Quality Controls
• Plasma-based
Controls
• Other IVD
Quality Controls
• Data Management
• Quality Assurance
Services
IVD Quality Control
Market End-use Outlook, by Revenue (USD Million), 2013 - 2024
• Home-care
• Laboratory
• Hospitals
• Others
For More Technical
Insights, Download Brochure @ https://www.millioninsights.com/industry-reports/in-vitro-diagnostics-ivd-quality-control-market
No comments:
Post a Comment